Article

European Journal of Human Genetics (2009) 17, 165–171; doi:10.1038/ejhg.2008.146; published online 20 August 2008

Long-term outcome of presymptomatic testing in Huntington disease

Marcela Gargiulo1,6, Séverine Lejeune1,6, Marie-Laure Tanguy2, Khadija Lahlou-Laforêt3, Anne Faudet1, David Cohen4, Josué Feingold1 and Alexandra Durr1,5

  1. 1Department of Genetics and Cytogenetics, AP-HP, Pitié-Salpêtrière Hospital, F-75013 Paris, France
  2. 2Department of Biostatistics, AP-HP Pitié-Salpêtrière Hospital, F-75013 Paris, France
  3. 3Service de Psychologie Clinique et Psychiatrie de Liaison, AP-HP Georges Pompidou European Hospital, F-75005 Paris, France
  4. 4Department of Child and Adolescent Psychiatry, AP-HP Pitié-Salpêtrière Hospital, CNRS FRE 2987, F-75013 Paris, France
  5. 5INSERM, UMR_S679 Neurologie & Thérapeutique Expérimentale, F-75013, Paris, France

Correspondence: Dr A Durr, INSERM U 679 and Department of Genetics and Cytogenetics, Pitié-Salpêtrière Hospital, 47 boulevard de l'Hôpital, 75013 Paris, France. Tel: + 33 1 42 16 21 82; Fax: + 33 1 44 24 36 58; E-mail: durr@ccr.jussieu.fr

6These authors contributed equally to this work.

Received 9 January 2008; Revised 10 July 2008; Accepted 11 July 2008; Published online 20 August 2008.

Top

Abstract

Our study on long-term outcome of presymptomatic testing for Huntington disease had two aims: the comparison of the psychological well-being and social adjustment of carriers and non-carriers of the mutation, and the identification of psychological determinants to improve care/support of testees. We performed a cross-sectional study of 351 persons who underwent presymptomatic testing. Those who had motor signs were excluded from the comparison of asymptomatic carrier and non-carriers. A structured interview including five self-report scales and the MINI (Mini International Neuropsychiatric Inventory) was proposed to detect a psychopathology or problem with social adjustment.

We interviewed 119 testees (53%), 62 non-carriers and 57 carriers after a mean delay of 3.7 years (range: 0.32 to 8.9) after their result. Depression was frequent in asymptomatic carriers (58%). Interestingly, the self reported impact of the test showed that 27% of non-carriers did not cope well with a favourable result, and a significant percentage of non-carriers (24%) were depressed during follow-up. Multivariate analysis showed that only a previous episode of depression was predictive of depression after genetic testing in both carriers and non-carriers of the HD mutation (P<0.0001).

Psychological support is necessary for all testees regardless of the result of their presymptomatic test, because psychiatric care is often needed by both carriers and non-carriers.

Keywords:

presymptomatic testing, Huntington disease, depression

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

REVIEWS

Wilson's disease: an update

Nature Clinical Practice Neurology Review (01 Sep 2006)

See all 11 matches for Reviews

Extra navigation

.
ADVERTISEMENT